Scholar Rock Holding Corporation (SRRK)
Healthcare • Biotechnology
StockNasdaqGSUnited StatesUS80706P1030
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Scholar Rock Holding Corporation, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 10:44. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 10 Nov 2026 07:00 | -0.84 | -0.81 | +4.0% | Beat |
| 06 Aug 2026 07:00 | -0.84 | -0.84 | +0.3% | In line |
| 07 May 2026 07:00 | -0.78 | -0.83 | -6.3% | Miss |
| 03 Mar 2026 07:00 | -0.88 | -0.88 | +0.3% | In line |
| 14 Nov 2025 07:00 | -0.84 | -0.90 | -7.8% | Miss |
| 06 Aug 2025 07:00 | -0.67 | -0.98 | -47.2% | Miss |
| 14 May 2025 07:00 | -0.71 | -0.67 | +5.3% | Beat |
| 27 Feb 2025 07:00 | -0.63 | -0.61 | +3.0% | Beat |
| 12 Nov 2024 07:00 | -0.59 | -0.66 | -12.2% | Miss |
| 08 Aug 2024 07:00 | -0.59 | -0.60 | -1.8% | Miss |
| 07 May 2024 07:00 | -0.51 | -0.59 | -16.5% | Miss |
| 19 Mar 2024 07:00 | -0.48 | -0.50 | -5.0% | Miss |
| 07 Nov 2023 07:00 | -0.51 | -0.53 | -3.2% | Miss |
| 09 Aug 2023 16:00 | -0.55 | -0.47 | +14.0% | Beat |
| 09 May 2023 07:00 | -0.52 | -0.49 | +6.5% | Beat |
| 07 Mar 2023 07:00 | -0.53 | -0.46 | +13.8% | Beat |
| 14 Nov 2022 08:00 | -0.64 | -0.55 | +13.4% | Beat |
| 08 Aug 2022 16:00 | -1.01 | -1.06 | -5.4% | Miss |
| 16 May 2022 16:00 | -0.53 | -0.21 | +60.6% | Beat |
| 07 Mar 2022 07:00 | -1.00 | -0.97 | +3.3% | Beat |
| 09 Nov 2021 08:00 | -0.76 | -1.02 | -34.8% | Miss |
| 10 Aug 2021 16:00 | -0.73 | -0.84 | -15.1% | Miss |
| 13 May 2021 07:00 | -0.65 | -0.76 | -17.4% | Miss |
| 09 Mar 2021 16:00 | -0.57 | -0.79 | -38.9% | Miss |
| 09 Nov 2020 08:00 | -0.50 | -0.79 | -58.0% | Miss |
| 07 Aug 2020 07:00 | -0.46 | -0.65 | -39.8% | Miss |
| 07 May 2020 17:00 | -0.46 | -0.58 | -26.1% | Miss |
| 12 Mar 2020 16:00 | -0.53 | -0.39 | +26.4% | Beat |
| 12 Nov 2019 07:00 | -0.41 | -0.55 | -32.5% | Miss |
| 14 Aug 2019 07:00 | -0.31 | -0.48 | -52.4% | Miss |
| 14 May 2019 16:00 | -0.32 | -0.42 | -29.2% | Miss |
| 18 Mar 2019 17:00 | -0.45 | -0.43 | +5.5% | Beat |
| 08 Nov 2018 17:00 | -0.56 | -0.44 | +21.4% | Beat |
| 08 Aug 2018 16:00 | -0.58 | -0.58 | 0.0% | In line |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 0 | — | -377.9M | — | -3.29 | -33.2% | -300.6M |
| 2024 | 0 | — | -246.3M | — | -2.47 | -24.1% | -201M |
| 2023 | 0 | -100.0% | -165.8M | — | -1.99 | +11.9% | -145.3M |
| 2022 | 33.2M | — | -134.5M | -405.2% | -2.26 | — | -133.8M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 12 Nov 2026 | 45.39 | 45.70 | 43.15 | 43.16 | -7.38% | 1,378,600 | |
| 11 Nov 2026 | 48.09 | 48.51 | 46.47 | 46.60 | -2.92% | 1,490,300 | |
| 10 Nov 2026 | 52.03 | 52.25 | 47.33 | 48.00 | -6.89% | 2,061,000 | |
| 09 Nov 2026 | 47.90 | 51.76 | 46.42 | 51.55 | +9.82% | 2,795,600 | |
| 06 Nov 2026 | 45.46 | 47.90 | 45.04 | 46.94 | +3.16% | 2,096,400 | |
| 05 Nov 2026 | 45.74 | 46.00 | 43.86 | 45.50 | -1.28% | 1,455,700 | |
| 04 Nov 2026 | 44.49 | 46.50 | 43.44 | 46.09 | +4.80% | 1,710,200 | |
| 03 Nov 2026 | 43.37 | 44.62 | 43.13 | 43.98 | +2.49% | 676,800 | |
| 02 Nov 2026 | 44.13 | 44.78 | 42.89 | 42.91 | -2.26% | 932,000 | |
| 30 Oct 2026 | 44.04 | 44.86 | 43.08 | 43.90 | -0.63% | 769,600 | |
| 1,249 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Scholar Rock (SRRK) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 10 Nov 2026 19:31
- What Scholar Rock (SRRK) Said on Its Q3 Earnings Call (opens in a new tab) MarketBeat · 10 Nov 2026 18:15
- What Scholar Rock Holding (SRRK)'s ISEMBYLD Launch Means For Shareholders (opens in a new tab) Simply Wall St. · 10 Nov 2026 15:09
- Scholar Rock (NASDAQ:SRRK) Q3 2026 Results: ISEMBYLD Launch, Revenue Beat, and Stock Pullback (opens in a new tab) ChartMill · 10 Nov 2026 13:33
- Scholar Rock Holding Corporation (SRRK) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 10 Nov 2026 13:01
- Scholar Rock Holding Corporation (SRRK) Reports Q3 Loss, Beats Revenue Estimates (opens in a new tab) Zacks · 10 Nov 2026 12:05
- Scholar Rock Reports Third Quarter 2026 Financial Results and Recent Business Highlights (opens in a new tab) 10 Nov 2026 12:00
- Scholar Rock Holding Q3 2026 Earnings Call Transcript (opens in a new tab) Benzinga · 10 Nov 2026 10:32
- BioNTech To Acquire FDA Priority Review Voucher From Scholar Rock For $205M In Cash (opens in a new tab) Benzinga · 10 Nov 2026 08:08
- Scholar Rock Holding Q3 EPS $(0.81) Beats $(0.85) Estimate, Sales $600.000K Beat $22.429K Estimate (opens in a new tab) Benzinga · 10 Nov 2026 08:01
- Scholar Rock to Present at Upcoming Investor Conferences (opens in a new tab) 03 Nov 2026 13:00
- Scholar Rock (SRRK) Stock Could Trade At A Premium On Balance Sheet Hopes (opens in a new tab) Simply Wall St. · 30 Oct 2026 09:13
- EMA Resubmission for Apitegromab Might Change The Case For Investing In Scholar Rock Holding (SRRK) (opens in a new tab) Simply Wall St. · 16 Oct 2026 02:20
- FDA Decision Watch: BMY, EGTX Face Key Decisions This Week As BFRI, SRRK And MIRM Score Early Approvals (opens in a new tab) Stocktwits · 28 Sep 2026 11:44
- Scholar Rock Poised for De-risked Commercial Ramp in Neuromuscular Space, Wedbush Says (opens in a new tab) MT Newswires · 25 Sep 2026 17:35
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 46.60 USD
- Market cap
- 5.3B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow SRRK and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.